JAK2 c.155_156delinsAC ;(p.A52D)

Variant ID: 9-5022142-CA-AC

NM_004972.3(JAK2):c.155_156delinsAC;(p.A52D)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Evolutionary action score identifies a subset of TP53 mutated myelodysplastic syndrome with favorable prognosis.

Blood Cancer Journal
Kanagal-Shamanna, Rashmi R; Montalban-Bravo, Guillermo G; Katsonis, Panagiotis P; Sasaki, Koji K; Class, Caleb A CA; Jabbour, Elias E; Sallman, David D; Hunter, Anthony Michael AM; Benton, Christopher C; Chien, Kelly S KS; Luthra, Rajyalakshmi R; Bueso-Ramos, Carlos E CE; Kadia, Tapan T; Andreeff, Michael M; Komrokji, Rami S RS; Al Ali, Najla H NH; Short, Nicholas N; Daver, Naval N; Routbort, Mark J MJ; Khoury, Joseph D JD; Patel, Keyur K; Ganan-Gomez, Irene I; Wei, Yue Y; Borthakur, Gautam G; Ravandi, Farhad F; Do, Kim-Anh KA; Soltysiak, Kelly A KA; Lichtarge, Olivier O; Medeiros, L Jeffrey LJ; Kantarjian, Hagop H; Garcia-Manero, Guillermo G
Publication Date: 2021-03-06

Variant appearance in text: JAK2: A52D
PubMed Link: 33677472
Variant Present in the following documents:
  • Main text
View BVdb publication page